Rchr
J-GLOBAL ID：202101021237362510
Update date: Dec. 20, 2025
Ono Takahiro
オノ タカヒロ | Ono Takahiro
Affiliation and department：
Job title：
assistant professor
Research field (1)：
Neurosurgery
Research keywords (3)：
nuclear medicine
, molecular biology
, glioma
Research theme for competitive and other funds (2)：
- 2024 - 2029 テクスチャ解析と分子解析に基づく、gliomaの病理診断法の刷新
- 2019 - 2023 IDH-wildtype gliomaにおける悪性化機構の解明
Papers (38)：
-
Shoto Tateoka, Takahiro Ono, Junta Moroi, Hajime Miyata, Takuya Furuta, Mayuko Moritsubo, Hiroshi Nanjo, Yoshitaka Narita, Hiroaki Shimizu. Comparative molecular analysis of primary and recurrent pleomorphic xanthoastrocytoma with BRAF mutation treated with combination therapy with dabrafenib and trametinib: a case report and literature review. International Cancer Conference Journal. 2025
-
Ryosei Wakasa, Takahiro Ono, Naomoto Senbokuya, Mikiko Kuwayama, Hiroaki Shimizu. Identifying the appropriate measurement environment for laser speckle flowmetry of cerebral blood flow in rats. Brain Research. 2025. 149443-149443
-
Masayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, Yukinori Akiyama, Takaaki Beppu, Shigeo Ohba, Toshiyuki Enomoto, Takahiro Ono, Yuta Mitobe, Mitsuto Hanihara, et al. Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection. International Journal of Clinical Oncology. 2024
-
Yuki Ono, Hiromitsu Shirasawa, Kazumasa Takahashi, Mayumi Goto, Takahiro Ono, Taichi Sakaguchi, Motonari Okabe, Takeo Hirakawa, Takuya Iwasawa, Akiko Fujishima, et al. Shape of the first mitotic spindles impacts multinucleation in human embryos. Nature Communications. 2024. 15. 1
-
Takahiro Ono, Hayato Suzuki, Hiroshi Nanjo, Hiroaki Shimizu. Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort. Journal of neuro-oncology. 2024
ｍore...
MISC (29)：
-
南條博, 廣嶋優子, 今井一博, 寺田かおり, 小野隆裕, 中村竜太, 大久保義真, 赤上陽一, 南谷佳弘. Automation of novel rapid-immunohistochemistry (R-IHC). 日本病理学会会誌. 2021. 110. 1
-
畠愛子, 小田正哉, 高橋和孝, 小野隆裕, 清水宏明. 視神経・視交叉に接触する非機能性下垂体腺腫に対する寡分割定位放射線治療の長期成績. 日本脳神経CI学会総会プログラム・抄録集(Web). 2021. 44th
-
小野隆裕, 高橋和孝, 清水宏明. 脳腫瘍術後てんかんの診断におけるarterial spin labelingの有用性. 日本脳神経CI学会総会プログラム・抄録集(Web). 2021. 44th
-
浅野研一郎, 山下洋二, 小野隆裕, 棗田学, 別府高明, 松田憲一朗, 市川優寛, 金森政之, 麓敏雄, 松坂方士, et al. 東北・新潟地区における高齢者悪性リンパ腫の臨床病理学的予後因子の検討-東北脳腫瘍研究会共同研究-. Brain Tumor Pathology (Web). 2021. 38. Supplement
-
南條博, 廣嶋優子, 寺田かおり, 今井一博, 小野隆裕, 中村竜太, 赤上陽一, 南谷佳弘. 免疫組織化学技術の発展 4.迅速免疫染色. 病理と臨床. 2020. 38
ｍore...
Education (2)：
- 2011 - 2015 Akita University Graduate School of Medicine
- 2003 - 2009 Akita University School of Medicine School of Medicine
Work history (4)：
- 2023/04 - 現在 Akita University Graduate School of Medicine Department of Neurosurgery Assistant Professor
- 2017/07 - 現在 Akita University Graduate Scholol of Medicine Department of Neurosurgery Assistant Professor
- 2015/11 - 2017/06 University Heidelberg Institute of Pathology, Department of Neuropathology Guest Researcher
- 2011/04 - 2015/10 Akita University Graduate School of Medicine Department of Neurosurgery
Awards (1)：
- 2022/06 - 山下太郎顕彰育英会 山下太郎学術研究奨励賞 病理学および分子生物学的解析を統合した、悪性髄内腫瘍の診断の最適化
Return to Previous Page
